Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Study: surgical abortion may harm sexual function more than medical abortion

NCT ID NCT07646275

Knowledge-focused Sponsor: Harran University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 86 women who had an early pregnancy loss (6-12 weeks) and chose either surgical or medical abortion. Researchers measured sexual function before the procedure and again 6 months later using a standard questionnaire. The surgical group showed a significant decline in sexual function, while the medical group did not. Because the study did not randomly assign treatments, these results are considered preliminary and need further confirmation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

88 people

The number who actually took part.

Started

Apr 2025

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 40 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * \- Diagnosis of early pregnancy loss (6-12 weeks gestation) * Planned to undergo either surgical or medical abortion * Age between 18 and 40 years * Proficiency in speaking and reading Turkish * Voluntary participation and provision of written informed consent Exclusion Criteria: * A known pre-existing diagnosis of sexual dysfunction (baseline FSFI total score ≤ 26.55) * A documented history of severe psychiatric disorders (e.g., schizophrenia, bipolar disorder) * History of chronic pelvic pain conditions (e.g., endometriosis, vulvodynia) or any other chronic medical condition known to significantly affect sexual function (e.g., unmanaged diabetes mellitus, multiple sclerosis) * Current use of medications that can impact sexual function (e.g., SSRIs, SNRIs, antipsychotics, antihypertensives) * Insufficient communication ability, defined as difficulty understanding and speaking Turkish or having cognitive/communication impairments that would prevent reliable completion of the study questionnaires

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Abortion, spontaneous are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Abortion, Spontaneous

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Abortion, spontaneous Early pregnancy loss Miscarriage Pregnancy (unwanted)

Contacts and locations

Locations

  • Harran University, Department of Gynecology and Obstetrics

    Sanliurfa, Şanliurfa, 63200, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.